In re Cendant Corp. Derivative Action Litigation

189 F.R.D. 117, 1999 WL 595030
CourtDistrict Court, D. New Jersey
DecidedAugust 9, 1999
DocketNo. CIV.A. 98-1998
StatusPublished
Cited by19 cases

This text of 189 F.R.D. 117 (In re Cendant Corp. Derivative Action Litigation) is published on Counsel Stack Legal Research, covering District Court, D. New Jersey primary law. Counsel Stack provides free access to over 12 million legal documents including statutes, case law, regulations, and constitutions.

Bluebook
In re Cendant Corp. Derivative Action Litigation, 189 F.R.D. 117, 1999 WL 595030 (D.N.J. 1999).

Opinion

[122]*122OPINION

WALLS, District Judge.

I. Introduction

This matter is before the Court on the motions of Cendant Corporation (“Cendant”), the HFS defendants, the CUC defendants, Bear Stearns, and the individual defendants E. Kirk Shelton, Amy Lipton, and Cosmo Corigliano to dismiss the verified amended derivative complaint (“complaint”) against them. The motion of defendants Shelton and Corigliano to dismiss Count I of the complaint is granted. The motion of defendant Bear Stearns to dismiss the complaint is granted. Defendant Lipton’s motion to dismiss the complaint against her for lack of personal jurisdiction is granted. The CUC defendants’ motion to dismiss Counts II and III against defendant Forbes is granted. All other motions are denied.

II. Background

At all relevant times, plaintiff Martin Deutch is and was a shareholder of nominal defendant Cendant. He brings this shareholder’s derivative action, on behalf and for the benefit of Cendant “to remedy the gross abuse of trust and loyalty committed by the defendants named [in the complaint], who include, inter alia, a majority of Cendant’s Board of Directors.” (Am.Compl. H1.) This suit arises out of the merger (the “Merger”) of CUC International, Inc. (“CUC”) with HFS Incorporated (“HFS”) to form Cendant on December 17,1997. During the next four months, Cendant’s stock price increased by 25%. (Id. at 114.) On April 15, 1998, after the close of the stock market, Cendant announced that due to “accounting irregularities” in certain former CUC business units, it expected to restate its annual and quarterly financial statements for 1997 and possibly for earlier periods as well. (Id. at 115.) Cendant estimated that it would reduce its 1997 income by $100-115 million and earnings per share by 11 to 13 cents. (Id. at KH 5, 88-89.) Cendant also announced that it had hired the law firm of Willkie Farr & Gallagher as special legal counsel which, in turn, hired Arthur Andersen LLP (the “independent investigators”) to perform an independent investigation. The next day, Cendant’s stock

fell by $16.56 per share or nearly 50%, and Cendant lost over $15 billion in market capitalization. (Id. at 11115, 91.) Shareholders filed suits under the securities laws in this and other districts against Cendant, its officers, directors, and other parties. On April 27,1998, plaintiff Deutch brought this derivative action against nominal defendant Cendant, its officers, directors, and Bear Stearns, the financial advisor to HFS about the Merger.

On July 14, 1998, Cendant announced that CUC’s income for the 1995, 1996, and 1997 fiscal years had been overstated by more than $500 million. (Id. at 116.) Following this announcement, on July 28, 1998, Cendant’s board of directors met with the independent investigators. (Id. at H 7.) On that day, Walter Forbes and nine former CUC directors agreed to resign. (Id. at HH7-8.) Finally, on August 28, 1998, Cendant filed with the SEC a report (“Report”) prepared by the independent investigators which disclosed that CUC and Cendant’s income.for 1995, 1996, and 1997 had been overstated by approximately $500 million. (Id. at 11117.) The Report concluded that these overstatements were achieved through improper topside adjustments to quarterly income, manipulation of merger reserves, accelerated revenue recognition, and the understatement of membership cancellation reserves. (Id.) On December 8, 1998, plaintiff filed this amended verified derivative complaint which defendants now move to dismiss.

Plaintiff alleges that Cendant’s twenty-eight directors (fourteen from CUC and fourteen from HFS) “improperly granted themselves and Cendant’s senior officers enormous financial incentives to complete the Merger and created enormous incentives for its investment banker, Bear Stearns to opine in favor of the Merger.” (Pl.’s Mem. at 2.) Plaintiff complains that “to ensure the Merger’s completion, Defendants issued numerous materially false and misleading statements regarding [Cendant’s] income and finances, and the Defendants’ due diligence in the Merger.” (Id.) Plaintiff Deutch did not demand that the directors of Cendant sue themselves because, he maintains, such demand would have been futile.

[123]*123Plaintiff has sued Cendant as a nominal defendant, together with the Bear Stearns Companies, Inc. and its subsidiary, Bear Stearns and Co., Inc., engaged by HFS as its advisor on the Merger (collectively the “Bear Stearns defendants”), and individual defendants who were officers and/or directors of Cendant. The individual defendants are Henry R. Silverman, Walter A. Forbes, T. Barnes Donnelley, Martin L. Edelman, Stanley Rumbough, Jr., John D. Snodgrass, Stephen P. Holmes, James E. Buckman, Bartlett Burnap, Burton C. Perfit, Michael P. Monaco, Christopher K. McLeod, Robert D. Kunisch, E. Kirk Shelton, Robert T. Tucker, E. John Rosenwald, Jr., Cosmo Corigliano, and Amy N. Lipton. (Am.Compl. 1118.) With the exception of defendants Lipton and Corigliano, the individual defendants comprised a majority of Cendant’s board of directors at the time this suit was filed and are referred to in the complaint as the “Director Defendants.” (Id.)

The complaint alleges that the individual defendants, “through their positions as senior officers and/or directors of [Cendant] and their receipt of reports, attendance at meetings and access to all of [Cendant’s] books, records and other proprietary information, had responsibility for, and therefore, material non-public information regarding, inter alia, (a) the accuracy and reliability of [Cendant’s] financial statements and/or accounting practices; and (b) [Cendant’s] true earnings.” (Am.Compl. H20.) Plaintiff asserts that with all this information, the individual defendants knew, or should have known, that Cendant’s publicly issued financial statements for 1997 were false because they did not conform to generally accepted accounting principles (“GAAP”). (Id. at II21.) According to the complaint, the individual defendants issued materially false and misleading statements regarding Cendant’s financial condition and the results of its operations. (Id. at 1122.) Plaintiff alleges that the individual defendants breached their fiduciary duty of loyalty because they, acting on material insider information, sold over four million shares of Cendant stock at artificially inflated prices to realize approximately $180 million for their own personal gain. (Id.)

The complaint charges that the individual defendants consummated the Merger for their own benefit. According to it, defendants Forbes and Silverman first discussed a possible merger in April, 1997. (Am.Compl. 1133.) On May 2, 1997, HFS engaged Bear Stearns, with which it had a long-standing relationship, as its financial advisor on the Merger. (Id. at 1135.) Defendant Silverman and the other HFS directors agreed to pay Bear Stearns a $4 million fee for a “fairness opinion” with regard to the Merger, and an additional $26 million if the Merger was consummated. (Id. at HH17, 36.) Plaintiff asserts that Bear Stearns and the HFS directors with access to CUC’s internal reports and documents failed to disclose that CUC had overstated its earnings by one-third. (Id. at 1139.) Plaintiff contends that both the HFS and CUC individual defendants consummated the Merger “to enhance their personal power and wealth.” (Id. at 1141.) As part of the Merger, defendants Silverman, Forbes, Shelton, McLeod, Monaco, Holmes, Buckman, Lipton, and Corigliano each received special compensation packages.

Free access — add to your briefcase to read the full text and ask questions with AI

Related

In re Galena Biopharma, Inc.
83 F. Supp. 3d 1047 (D. Oregon, 2015)
In re Polycom, Inc.
78 F. Supp. 3d 1006 (N.D. California, 2015)
In re Johnson & Johnson Derivative Litigation
865 F. Supp. 2d 545 (D. New Jersey, 2011)
Sherman v. Ryan
911 N.E.2d 378 (Appellate Court of Illinois, 2009)
Johnson v. Glassman
950 A.2d 215 (New Jersey Superior Court App Division, 2008)
In Re Veeco Instruments, Inc. Securities Litigation
434 F. Supp. 2d 267 (S.D. New York, 2006)
In Re Cray Inc.
431 F. Supp. 2d 1114 (W.D. Washington, 2006)
In Re Sonus Networks, Inc. Shareholder Derivative
422 F. Supp. 2d 281 (D. Massachusetts, 2006)
In Re: Cendant Corp
Third Circuit, 2001
P. Schoenfeld Asset Management LLC v. Cendant Corp.
142 F. Supp. 2d 589 (D. New Jersey, 2001)
In Re Cendant Corp. Securities Litigation
124 F. Supp. 2d 235 (D. New Jersey, 2000)
In Re Cendant Corp. Derivative Action Litigation
96 F. Supp. 2d 394 (D. New Jersey, 2000)
In re Oxford Health Plans, Inc.
192 F.R.D. 111 (S.D. New York, 2000)
Yeager v. Cendant Corp.
190 F.R.D. 331 (D. New Jersey, 1999)
Daystar Special Situations Fund L.P. v. Cendant Corp.
76 F. Supp. 2d 531 (D. New Jersey, 1999)

Cite This Page — Counsel Stack

Bluebook (online)
189 F.R.D. 117, 1999 WL 595030, Counsel Stack Legal Research, https://law.counselstack.com/opinion/in-re-cendant-corp-derivative-action-litigation-njd-1999.